These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27967239)

  • 61. Metabolomics: a promising diagnostic and therapeutic implement for breast cancer.
    Chen Z; Li Z; Li H; Jiang Y
    Onco Targets Ther; 2019; 12():6797-6811. PubMed ID: 31686838
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Breast cancer metastasis to bone: it is not all about PTHrP.
    Bendre M; Gaddy D; Nicholas RW; Suva LJ
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
    Futakuchi M; Fukamachi K; Suzui M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipid Osteoclastokines Regulate Breast Cancer Bone Metastasis.
    Krzeszinski JY; Schwaid AG; Cheng WY; Jin Z; Gallegos ZR; Saghatelian A; Wan Y
    Endocrinology; 2017 Mar; 158(3):477-489. PubMed ID: 27967239
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.
    Jiang P; Gao W; Ma T; Wang R; Piao Y; Dong X; Wang P; Zhang X; Liu Y; Su W; Xiang R; Zhang J; Li N
    Theranostics; 2019; 9(10):2950-2966. PubMed ID: 31244935
    [No Abstract]   [Full Text] [Related]  

  • 66. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
    Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.
    Kurio N; Shimo T; Fukazawa T; Takaoka M; Okui T; Hassan NM; Honami T; Hatakeyama S; Ikeda M; Naomoto Y; Sasaki A
    Exp Cell Res; 2011 May; 317(8):1134-46. PubMed ID: 21338601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.
    Pollari S; Käkönen SM; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O
    Breast Cancer Res Treat; 2011 Jan; 125(2):421-30. PubMed ID: 20352489
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice.
    Nakamura H; Hiraga T; Ninomiya T; Hosoya A; Fujisaki N; Yoneda T; Ozawa H
    J Bone Miner Metab; 2008; 26(6):642-7. PubMed ID: 18979165
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IL-1 drives breast cancer growth and bone metastasis in vivo.
    Holen I; Lefley DV; Francis SE; Rennicks S; Bradbury S; Coleman RE; Ottewell P
    Oncotarget; 2016 Nov; 7(46):75571-75584. PubMed ID: 27765923
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipid metabolic reprogramming in cancer cells.
    Beloribi-Djefaflia S; Vasseur S; Guillaumond F
    Oncogenesis; 2016 Jan; 5(1):e189. PubMed ID: 26807644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects.
    Wei W; Schwaid AG; Wang X; Wang X; Chen S; Chu Q; Saghatelian A; Wan Y
    Cell Metab; 2016 Mar; 23(3):479-91. PubMed ID: 26777690
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.
    Weivoda MM; Ruan M; Hachfeld CM; Pederson L; Howe A; Davey RA; Zajac JD; Kobayashi Y; Williams BO; Westendorf JJ; Khosla S; Oursler MJ
    J Bone Miner Res; 2016 Jan; 31(1):65-75. PubMed ID: 26189772
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.
    Raynor A; Jantscheff P; Ross T; Schlesinger M; Wilde M; Haasis S; Dreckmann T; Bendas G; Massing U
    Lipids Health Dis; 2015 Jul; 14():69. PubMed ID: 26162894
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
    Krzeszinski JY; Wei W; Huynh H; Jin Z; Wang X; Chang TC; Xie XJ; He L; Mangala LS; Lopez-Berestein G; Sood AK; Mendell JT; Wan Y
    Nature; 2014 Aug; 512(7515):431-5. PubMed ID: 25043055
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.
    Zhou JZ; Riquelme MA; Gao X; Ellies LG; Sun LZ; Jiang JX
    Oncogene; 2015 Apr; 34(14):1831-42. PubMed ID: 24837364
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.